More from MIM

| No Comments
joe-gabon-2139.jpg

Hello from the Kenyatta International Conference Center in Nairobi, Kenya!

 

It is a privilege to be here among the world's leading malaria researchers. I've had a busy first day already--connecting with colleagues old and new and attending plenaries, symposiums and scientific sessions.

 

I am really looking forward to tomorrow since we'll have a chance to update the media and many African journalists about RTS,S.

 

It's great to see the awareness grow about the vaccine--including an important commentary piece in The Lancet by the conference organizers. How few people would have imagined this historic milestone a few years ago?

 

Tomorrow, joining me at the media briefing, will be two African Principal Investigators who can explain what goes on to make this possible. Salim Abdulla and Patricia Njuguna are just two of the world-class African scientists in Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania who are spearheading this effort. In the months leading up to Phase III, they have coordinated an incredible amount of training and capacity building just to get the trial off the ground. Their leadership has been extraordinary and just another reason why there is so much excitement here.

 

Will report back again after tomorrow's briefing...

Leave a comment

Follow GSKUS on Twitter
BlogWithIntegrity.com

About this Entry

This page contains a single entry by Joe C, GSK Vaccines R & D published on November 2, 2009 4:26 PM.

Malaria Vaccine in Final Stretch was the previous entry in this blog.

ViiV Healthcare--A New Type of HIV Company is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.